| U.S. DEPARTMENT OF LABOR | OFFICE OF WORKERS' COMPENSATION PROGRAMS DIVISION OF ENERGY EMPLOYEES OCCUPATIONAL ILLNESS COMPENSATION FINAL ADJUDICATION BRANCH |
|
EMPLOYEE: |
[Name Deleted] |
|
CLAIMANT: |
[Name Deleted] |
|
FILE NUMBER: |
[Number Deleted] |
|
DOCKET NUMBERS: |
50245-2004 10031393-2007 |
|
DECISION DATE: |
April 14, 2011 |
This is the response to the
claimant’s December 28, 2010 request for reconsideration of the November 30,
2010 decision of the Final Adjudication Branch (FAB) on his survivor claim
under both Part B and Part E of the Energy Employees Occupational Illness
Compensation Program Act of 2000, as amended (EEOICPA), 42 U.S.C. § 7384 et seq.
In that decision, FAB concluded that with respect to Part B, the
employee’s pancreatic cancer was not sustained “in the performance of duty,” as
that term is defined in § 7384n(b), because it is not “at least as likely as
not” (a 50% or greater probability) that such cancer was related to the radiation
doses she received during her covered employment at a Department of Energy (DOE)
facility—Hangar 481, Kirtland Air Force Base (AFB)—from March 1, 1989 through
June 30, 1994. FAB also concluded that
with respect to Part E of EEOICPA, the employee was not a “covered DOE
contractor employee,” as that term is defined in § 7385s(1), because it is also
not at least as likely as not that her exposure to toxic substances at Hangar
481 was a significant factor in aggravating, contributing to, or causing her
pancreatic cancer. It was because of these
two conclusions that the claim for survivor benefits due to the employee’s
pancreatic cancer under Part B, and for her death due to pancreatic cancer
under E, was denied. A decision on the
Part E claim for the employee’s death due to acoustic neuroma, however, was
deferred pending further development.
In support of his December
28, 2010 reconsideration request, the claimant raised a number of interwoven
and somewhat confusing arguments. To the
extent that I can discern what they are, his arguments in support of his
request are as follows.
1. FAB should have found that the period of the
employee’s covered employment began when she started work for Ross Aviation at
Hangar 481, Kirtland AFB, on December 9, 1985, rather than when Hangar 481
became a covered DOE facility on March 1, 1989, because Ross Aviation had
contracts with DOE and its predecessor agencies starting in 1970, and because those
contracts show that Ross Aviation began working at Hangar 481 in 1984. In conjunction with this argument, which the
claimant raised earlier in the adjudication of his claim, he asserts that
copies of the contracts in question that he submitted have either never been
considered, or were not considered by the appropriate agency of the Department
of Labor.
2. FAB wrongly found that the employee’s
diagnosed acoustic neuroma was not an “occupational illness” that is
compensable under Part B that should have been taken into account during the
dose reconstruction process and the determination of the probability of
causation for the Part B claim.
3. FAB wrongly concluded that the effect of the
employee’s alleged exposure to radiation prior to beginning her employment with
Ross Aviation on December 9, 1985, as well as her alleged “non-employment”
exposure during her accepted covered employment, could not be taken into
account when it determined the probability of causation for her pancreatic
cancer. The claimant contends that these
alleged exposures to radiation can be inferred from evidence in the file and must
be taken into account, because 42 U.S.C. § 7384n(c)(3)(C) provides that the regulatory
guidelines for determining the probability of causation for cancer under Part B
“shall take into consideration. . .other relevant factors.” As was the case with the claimant’s first
argument noted above, he made this particular argument previously in the
adjudication of his claim.
4. FAB wrongly concluded that the alleged radiation
exposure of the employee “in other employments” was not covered under
EEOICPA. The claimant contends that this
alleged radiation exposure should have been taken into account and “added to
the worker’s total exposure. . . .”
While he acknowledges that the dose reconstruction methodology that the
National Institute for Occupational Safety and Health (NIOSH) used to estimate
the radiation dose of the employee is binding on FAB, he believes that FAB
should have determined that his objections concerning the application of that
methodology, as it related to the alleged exposures in question, needed to be
considered by NIOSH and therefore should have returned the Part B claim to the
district office for referral to NIOSH for such consideration. To support this argument regarding the
employee’s radiation dose, he asserts that:
[G]eneral
principles of workers [sic]
compensation law contemplate that a worker who was exposed to radiation in
multiple employments, like the worker in this case, is not limited to an
analysis of exposure during the last term of injurious employment. Rather, in such cases the sum total of the
worker’s exposure during successive employments should be taken into account in
assessing the effect of the worker’s last injurious exposure to radiation, and
in so doing the exposure with the last employer. . .is given its due weight in
contributing to the onset of a subsequently occurring cancer.
Similar to the first and
third arguments listed above, the claimant raised this argument previously in
the adjudication of his EEOICPA claim.
5. The claimant was not afforded the opportunity
to present his objections regarding the dose reconstruction for the employee to
NIOSH, which he acknowledges is “the agency which most logically has the
expertise to evaluate the merits” of his position. Therefore, the claimant believes that FAB
should have returned his Part B claim to the district office for referral to
NIOSH so it could consider his contention that the dose reconstruction for the
employee should have included her non-employment and “other employments”
exposures.
After careful consideration
of these arguments, and for the reasons set forth below, the request for
reconsideration is hereby denied.
With regard to the first argument
noted above, and as set out in FAB’s November 30, 2010 decision, there is no
dispute that Ross Aviation performed work under contracts it had with DOE and
its predecessor agencies as early as February of 1970, and that the evidence
establishes that the employee started working for Ross Aviation on December 9,
1985. The pertinent question for the
purposes of the claimant’s survivor claim, however, concerns where Ross Aviation
did its work under its contracts with DOE that covered the period of the
employee’s employment from December 9, 1985 through June 30, 1994. Contrary to the claimant’s allegations noted
above, the contracts at issue have, in fact, been previously reviewed by the
Director of the Division of Energy Employees Occupational Illness Compensation
(DEEOIC), which is the division of the Office of Workers’ Compensation Programs
that administers EEOICPA[1],
when NIOSH provided her with copies of them and asked, in a September 30, 2009
letter regarding the petition to add a class of employees at Hangar 481 to the
Special Exposure Cohort the claimant filed with NIOSH, whether those contracts were
sufficient to expand the “covered” period of Hangar 481 as a DOE facility. In her February 2, 2010 response, the
Director noted that after carefully reviewing those contracts, it was her
conclusion that they did not support changing the determination that Ross
Aviation was a DOE contractor at Hangar 481, Kirtland AFB, for the period March
1, 1989 through February 29, 1996. Those
same contracts were also carefully considered yet again when the claimant
submitted copies of them to the case file in support of his claim, and are
briefly described below:
As noted above, and as
previously stated in FAB’s November 30, 2010 decision, there is no probative
and persuasive evidence specifying that Ross Aviation performed its work under
a contract with DOE at Hangar 481, Kirtland AFB, prior to March 1, 1989. In this regard, and again as pointed out by
FAB in the November 30, 2010 decision, the non-contractual evidence the
claimant submitted in support of this argument is of diminished probative value
when compared to the actual contracts described above. Accordingly, there is no basis for extending
the covered period for that facility to include the earlier period that the
employee worked there beginning on December 9, 1985, and this argument does not
warrant reconsideration of FAB’s November 30, 2010 decision.
As for the second argument
described above, FAB’s November 30, 2010 decision specifically informed the
claimant that acoustic neuroma is not an “occupational illness,” as that term
is defined in § 7384l(15), and therefore is not compensable under Part B. While he contends that acoustic
neuroma is a cancer and therefore it should have been taken into account by
NIOSH when it reconstructed the employee’s radiation dose and by DEEOIC when it
determined the probability of causation based on that dose reconstruction,
acoustic neuroma is actually a benign tumor
of the eighth cranial nerve. The only
reference to that illness in the medical evidence is in an August 11, 2000
report by Dr. Jorge Sedas, in which Dr. Sedas related the employee’s history of
a “right-sided acoustic tumor – stable”; there is no medical evidence in the
file showing that the reported tumor was malignant (cancer). The provisions of 42 U.S.C. § 7384n(b), (c),
and (d) regarding the dose reconstruction process and the determination of probability
of causation are applicable only for the purpose of determining whether cancer was sustained in the performance
of duty. For those reasons, this second
argument also does not warrant reconsideration of the November 30, 2010
decision of FAB.
In the third argument
described above, the claimant contends that FAB should have taken the employee’s
alleged exposure to radiation prior to beginning her employment with Ross
Aviation and her alleged non-employment exposure during her accepted covered
employment, which he asserts can be inferred from the evidence in the file,
into account as “other relevant factors” when it determined the probability of
causation for the employee’s pancreatic cancer under Part B. While he is correct that § 7384n(c)(3)(C) of
EEOICPA directs that the regulatory guidelines for determining the probability
of causation for cancer claimed under Part B “shall take into consideration. .
.other relevant factors,” the task of devising
these guidelines (and taking those “other relevant factors” into account)
pursuant to that statutory directive was assigned to the Secretary of Health
and Human Services (HHS), not the Secretary of Labor, by the President in Sec. 2(b)(i)(A)
of Executive Order 13179 of December 7,
2000. 65 Fed. Reg. 77487 (December 11,
2000).[3] While DEEOIC is required by 42 C.F.R. § 81.20(b)
to apply the HHS regulatory guidelines,
which have been incorporated into the NIOSH Interactive RadioEpidemiological
Program (NIOSH-IREP), DEEOIC does not have the authority to alter the guidelines to take into
account the particular non-covered employment exposures the claimant alleges
that the employee experienced both prior to and away from her covered employment
at Hangar 481 as “other relevant factors” when determining the probability of
causation for her pancreatic cancer under Part B. On the contrary, as Paragraph 2.0 of the User’s Guide the for the Interactive
RadioEpidemiological Program (NIOSH-IREP) states:
The
NIOSH-IREP computer code is a web-based program that estimates the probability
that an employee’s cancer was caused by his or her individual radiation
dose. Personal information (e.g., birth year, year of cancer
diagnosis, gender) and exposure information (e.g., exposure year, dose) may be entered manually or through the
use of an input file. For application by
the U.S. Department of Labor (DOL), the
input file option is used to preset all personal information, exposure
information, and system variables. These
input files are created by NIOSH for each individual claim and transmitted to
the appropriate DOL district office for processing.[4]
(emphasis added)
Accordingly, the claimant’s
third argument also does not warrant granting his request to reconsider FAB’s
November 30, 2010 decision.
In the fourth argument in support
of the claimant’s request, he contends that the employee’s alleged radiation
exposures “in other employments” should have been taken into account and “added
to the worker’s total exposure” as “other relevant factors.” As FAB’s November 30, 2010 decision noted, the
issue of what radiation dose to include is exclusively under the control of
NIOSH, pursuant to the President’s assignment of the task of performing dose
reconstructions to the Secretary of HHS (which then re-delegated it to NIOSH)
in Sec. 2(b)(iii) of Executive Order 13179.
Also, the statute itself, at § 7384n(d)(1), restricts the dose to be
used to determine probability of causation to radiation exposure that occurred solely
“at a facility,” which in the employee’s case, means the dose she received when
Hangar 481 was a DOE facility—March 1, 1989 through June 30, 1994. HHS has issued regulations governing the dose
reconstruction process at 42 C.F.R. part 82, and those regulations do not provide
for any consideration of pre-employment and non-employment radiation exposures
in estimating radiation dose incurred at a DOE facility, regardless of the
claimant’s belief that principles of workers’ compensation require such
consideration. Because consideration of
the “other relevant factors” referred to in 42 U.S.C. § 7384n(c)(3)(C), which
as noted above, refers solely to the determination of probability of causation,
this fourth argument also does not warrant reconsideration of the November 30,
2010 FAB decision on the claim.
Finally, in the fifth
argument, the claimant asserts that FAB should have returned his Part B claim
to the district office for referral to NIOSH, so NIOSH could consider his
contention that the dose reconstruction for the employee should have included
non-employment and “other employments” exposures. While there is no dispute that NIOSH is “the
agency which most logically has the expertise to evaluate the merits” of his
position, the fact remains that the claimant was provided with the opportunity,
at multiple points during the dose reconstruction process at NIOSH, to submit
whatever evidence he had regarding the employee’s radiation exposures for
consideration by NIOSH. Further, as
discussed above, the types of exposures at issue here are simply not covered
under EEOICPA. Therefore, there was no
reason for FAB to return the Part B claim to the district office for referral
to NIOSH, and this final argument, like the preceding four, does not provide a
sufficient basis for reconsidering FAB’s November 30, 2010 decision.
I must deny the request for
reconsideration because the claimant has not submitted any argument or evidence
which justifies reconsideration of the November 30, 2010 final decision.
That decision of FAB is therefore final on the date of issuance of this denial
of the request for reconsideration. See
20 C.F.R. § 30.319(c)(2).
Hearing
Representative
Final
Adjudication Branch
[1] The sources of authority for administering EEOICPA are set out at 20 C.F.R. § 30.1,which states that the Director of the Office of Workers’ Compensation Programs (and his designee the Director of DEEOIC) has the primary responsibility to administer EEOICPA, except for those activities assigned to other agencies. This responsibility includes the “exclusive authority to. . . interpret the provisions of EEOICPA,” among them the statutory definition of “Department of Energy facility” at § 7384l(12).
[2] The case file also contains numerous other modifications of Contract No. DE-AC04-76DP03276, but those other modifications also do not include a “Statement of Work” provision identifying the location where Ross Aviation was to perform its work; thus, they are not described above. For example, modification number M062 extended the provisions of that contract to cover the period from March 1, 1984 through February 28, 1989 (during which the employee began working for Ross Aviation), but contained no language whatsoever that described where Ross Aviation performed its work for DOE.
[3] See also 20 C.F.R. § 30.2(b) (“. . .HHS has promulgated regulations at 42 CFR part 81 that set out guidelines that OWCP follows when it assesses the compensability of an employee’s radiogenic cancer”) and 20 C.F.R. § 30.213(b) (“HHS’s regulations satisfy the legal requirements in section 7384n(c) of the Act, which also sets out OWCP’s obligation to use them in its adjudication of claims for radiogenic cancer filed under Part B of the Act, and provide the factual basis for OWCP to determine if the ‘probability of causation’ (PoC) that an employee’s cancer was sustained in the performance of duty is 50% or greater (i.e., it is ‘at least as likely as not’ causally related to employment), as required under section 7384n(b)”).
[4] See: http://www.cdc.gov/niosh/ocas/pdfs/irep/irepug56.pdf(last visited April 13, 2011).